![Substituted pyrrolo[2,1-f][1,2,4]triazines as kinase inhibitors](/docs/US/2021-08-10/US11084823B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted pyrrolo[2,1-f][1,2,4]triazines as kinase inhibitors
-
申请号： US16478920申请日： 2018-03-19
-
公开(公告)号： US11084823B2公开(公告)日： 2021-08-10
- 发明人: In Woo Kim , Ja Kyung Yoo , Ji Duck Kim , Sun Ah Jun , Jun Hee Lee
- 申请人： Daewoong Pharmaceutical Co., Ltd.
- 申请人地址： KR Gyeonggi-do
- 专利权人： Daewoong Pharmaceutical Co., Ltd.
- 当前专利权人： Daewoong Pharmaceutical Co., Ltd.
- 当前专利权人地址： KR Gyeonggi-do
- 代理机构： Marshall, Gerstein & Borun LLP
- 优先权： KR10-2017-0034059 20170317
- 国际申请： PCT/KR2018/003140 WO 20180319
- 国际公布： WO2018/169373 WO 20180920
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; C07D487/04 ; C07D519/00
![Substituted pyrrolo[2,1-f][1,2,4]triazines as kinase inhibitors](/abs-image/US/2021/08/10/US11084823B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
公开/授权文献
- US20210130358A1 Pyrrolotriazine Derivatives as Kinase Inhibitor 公开/授权日：2021-05-06
信息查询
IPC分类:
